 A panel of experts advising the FDA unanimously backed the drug last month. Side effects can include headache as well as brain swelling and bleeding. Lilly says the drug, given as a monthly infusion, will cost $32,000 for a year of treatment. That's a little more than an older, similar drug called Lekembe, which has to be taken every two weeks indefinitely.